Supriya Lifescience Crescita futura
Future criteri di controllo 3/6
Supriya Lifescience is forecast to grow earnings and revenue by 14.3% and 20.7% per annum respectively. EPS is expected to grow by 14.4% per annum. Return on equity is forecast to be 16% in 3 years.
Informazioni chiave
14.3%
Tasso di crescita degli utili
14.4%
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 18.4% |
Tasso di crescita dei ricavi | 20.7% |
Rendimento futuro del capitale proprio | 16.0% |
Copertura analitica | Low |
Ultimo aggiornamento | 29 Oct 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80
Sep 08We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings
Jun 05Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings
May 10Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E
Feb 09Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit
May 28Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower
May 07Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
3/31/2027 | 10,345 | 2,214 | N/A | 1,678 | 1 |
3/31/2026 | 8,410 | 1,788 | N/A | 1,368 | 1 |
3/31/2025 | 6,838 | 1,596 | N/A | 1,336 | 1 |
9/30/2024 | 6,250 | 1,575 | -189 | 1,495 | N/A |
6/30/2024 | 5,990 | 1,352 | N/A | N/A | N/A |
3/31/2024 | 5,704 | 1,191 | -323 | 1,133 | N/A |
12/31/2023 | 5,545 | 1,204 | N/A | N/A | N/A |
9/30/2023 | 5,195 | 1,001 | 72 | 1,322 | N/A |
6/30/2023 | 4,916 | 931 | N/A | N/A | N/A |
3/31/2023 | 4,609 | 899 | -443 | 636 | N/A |
12/31/2022 | 5,069 | 978 | N/A | N/A | N/A |
9/30/2022 | 5,188 | 1,280 | -191 | 226 | N/A |
6/30/2022 | 5,545 | 1,693 | N/A | N/A | N/A |
3/31/2022 | 5,300 | 1,518 | -111 | 488 | N/A |
12/31/2021 | 4,754 | 1,543 | N/A | N/A | N/A |
3/31/2021 | 3,912 | 1,236 | 276 | 759 | N/A |
3/31/2020 | 3,200 | 734 | 915 | 1,161 | N/A |
3/31/2019 | 2,818 | 394 | 417 | 487 | N/A |
3/31/2018 | 2,168 | 87 | N/A | 278 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: SUPRIYA's forecast earnings growth (14.3% per year) is above the savings rate (6.7%).
Guadagni vs Mercato: SUPRIYA's earnings (14.3% per year) are forecast to grow slower than the Indian market (18.1% per year).
Guadagni ad alta crescita: SUPRIYA's earnings are forecast to grow, but not significantly.
Ricavi vs Mercato: SUPRIYA's revenue (20.7% per year) is forecast to grow faster than the Indian market (10.2% per year).
Ricavi ad alta crescita: SUPRIYA's revenue (20.7% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: SUPRIYA's Return on Equity is forecast to be low in 3 years time (16%).